核医学急性并发症:急诊医学视角的叙述性综述
诊断用放射性药物总体安全,外渗常见但极少导致临床显著伤害;治疗用放射性药物并发症临床意义更大,需提高警惕并请专科会诊。
要点
- 诊断用放射性药物急性事件罕见,外渗常见但极少造成临床显著伤害,以支持治疗为主。
- 治疗用放射性药物外渗与毒性临床意义更大,尤其高能β发射体,需警惕并请专科会诊。
- 镥-177标记治疗毒性可预测,血液学不良事件是急诊主要关注点;锕-225-PSMA-617可伴口干和血液学毒性。
核心结论
- 核医学操作相关急性事件不常见但在急诊实践中具有临床相关性。
- 诊断用放射性药物总体安全、以支持治疗为主,治疗用放射性药物并发症需高度警惕并请专科会诊。
研究设计与样本
- 纳入报告放射性药物给药相关急性事件(包括外渗、过敏反应、给药错误和放射性污染)的研究。
- 因方法学异质性,对队列研究、监测登记、系统综述和相关病例报告的证据进行叙述性综合。
主要发现
- 系统性评估时诊断用放射性药物外渗常见,但极少导致临床显著伤害。
- 严重过敏反应和过敏性休克极为罕见。
- 给药错误事件发生不频繁,主要与诊断性操作相关,多数病例患者伤害轻微。
- 治疗用放射性药物(尤其高能β发射体)相关外渗和毒性具有更大的临床意义。
- 镥-177标记治疗显示可预测的毒性特征,血液学不良事件是急诊主要关注问题;锕-225-PSMA-617显示有前景的疗效,但可能与临床相关口干和血液学毒性相关。
临床怎么用
- 急诊医师应熟悉核医学操作后急性事件的临床表现,以便及时识别和处理。
- 诊断用放射性药物相关急性事件以支持治疗为主。
- 治疗用放射性药物并发症需提高警惕并及时请核医学专科会诊,尤其在缺乏现场核医学专业人员的机构。
局限性
- 因纳入研究方法学异质性,证据采用叙述性综合而非定量合并。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nuclear medicine procedures are increasingly integrated into routine clinical practice worldwide, including in low- and middle-income settings. Although radiopharmaceuticals have a well-established safety profile, the growing volume of diagnostic and therapeutic procedures means that acute adverse events, while uncommon, are encountered with sufficient frequency to present to emergency departments. Emergency physicians are often the first clinicians to assess patients with post-procedural symptoms, yet guidance tailored to emergency care remains limited. This review aims to provide an emergency medicine-focused synthesis of the incidence, clinical presentation, and acute management of adverse events associated with nuclear medicine procedures.We conducted a narrative review using a systematic search strategy across PubMed/MEDLINE, Embase, Scopus, and the Cochrane Library, covering publications from January 2020 to December 2024. Studies reporting acute events related to radiopharmaceutical administration, including extravasation, allergic reactions, maladministration, and radiation contamination, were included. Evidence from cohort studies, surveillance registries, systematic reviews, and relevant case reports was synthesized narratively due to methodological heterogeneity. MAIN BODY: Sixty-eight studies encompassing over two million radiopharmaceutical administrations were included. Diagnostic radiopharmaceutical extravasation was common when systematically assessed but rarely resulted in clinically significant harm. Severe allergic reactions and anaphylaxis were exceedingly rare. Maladministration events occurred infrequently and were predominantly associated with diagnostic procedures, with minimal patient harm in most cases. In contrast, extravasation and toxicity related to therapeutic radiopharmaceuticals, particularly high-energy beta emitters, carried greater clinical significance. Newer agents such as lutetium-177-labelled therapies demonstrated predictable toxicity profiles, with hematologic adverse events representing the primary emergency care concern.Emerging alpha-emitting theranostic agents such as actinium-225-PSMA-617 demonstrate promising efficacy but may be associated with clinically relevant xerostomia and hematologic toxicity. CONCLUSION: Acute events related to nuclear medicine procedures are uncommon but clinically relevant in emergency practice. Diagnostic radiopharmaceuticals are generally safe and require supportive management, whereas therapeutic radiopharmaceutical complications warrant heightened vigilance and specialist consultation. Familiarity with these presentations can support timely, appropriate emergency care, particularly in settings with limited on-site nuclear medicine expertise.
引用
- Sutaşır MN, Arslan B, Mohamed MM, et al. Acute complications of nuclear medicine: an emergency medicine perspective. EJNMMI Res. 2026. PMID: 42247081. doi:10.1186/s13550-026-01464-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。